In his original monograph, Wilson described the disease which is now named for him as ". . . familial, in the sense that frequently more than one member of a family is affected with it, but. . . not hereditary" (1) . Subsequent studies (2-4) have indicated, however, that the disease is hereditary and is transmitted in autosomal recessive fashion by parents who never develop the illness. This implies both that Wilson's disease appears in those subjects who are homozygous for the "Wilson's disease gene" and that each parent of such a subject must be a heterozygote who possesses one of these abnormal genes and one of its normal alleles. We have chosen to designate the genotypes of patients, heterozygotes, and normal individuals, respectively, as cc, Cc, and CC.
The patient in whom Wilson's disease is, or will be, clinically manifest exhibits four abnormalities of copper metabolism: 1) a persistent deficiency or absence of normal ceruloplasmins, the blue, plasma copper-proteins (3, 5, 6) ; 2) an increased concentration of loosely bound, non-ceruloplasmin copper in serum (6, 7); 3) an increased copper content of many organs and tissues (6, the urine (3, 6, 11, 14) . Although the mechanism is only partly understood, several investigators (3, 11, 15, 16) believe that the first two of these derangements lead to the third, the pathological effects of which constitute Wilson's disease.
The symptoms and physical signs of Wilson's disease never develop in the heterozygotes, and it is even unusual for them to manifest any of these four abnormalities. Considering these respectively, we find that 1) of 49 parents 1 of patients in whom serum ceruloplasmin concentrations were measured, directly or indirectly, only 10 showed a decreased concentration 'of this protein; 2) of 4 parents in whom appropriate observations were made, only 1 showed an increased concentration of loosely bound, non-ceruloplasmin copper in serum (7); 3) there is no information concerning concentrations of tissue copper in parents of patients; and 4) parents have never been shown to exhibit hypercupriuria (17, 19 (18, (24) (25) (26) (27) (28) Antilog (mean log R) 1.372 Antilog (mean log R + SD log R) 2.057 Antilog (mean log R -SD log R) (33) , and, since these subjects were almost Antilog (mean log R) 0.510 Antilog (mean log R + SD log R) 0.852
Antilog (mean log R -SD log R) 0.305 * The italicized numbers represent the peak concentrations of Cu'4 at 1 or 2 hours after feeding. all hospitalized patients, it is likely that such nonspecific elevations account for the high values found.
In all control subjects, for each sampling time, the mean fraction of the administered dose of Cu64 present in 1 ml of serum was calculated from the individual determinations. A curve through these five means, observed at 1, 2, 4, 24 and 48 hours after administration of Cu64, is shown in Figure 1 . Similarly computed curves are given for the patients (Group II) and heterozygotes (Group III) in Figures 2 and 3 , respectively. No "mean curve" was made for Group IV because of the heterogeneity of this group. DISCUSSION A. Differentiation of the genotypes cc, Cc and CC. The subject, cc, who inherits two Wilson's disease genes can almost always be detected when first seen by the physician (16) . He may already have developed the hepatic or neurologic findings and Kayser-Fleischer rings which are characteristic of Wilson's disease. If so, one can be certain of the diagnosis without even determining if other clinical or biochemical characteristics of the disease are present. However, if the subject is asymptomatic, the demonstration of 1) a serum concentration of normal ceruloplasmins which is persistently less than 15 mg per 100 ml (5, 34, 35) ; 2) more than 30 Mtg of non-ceruloplasmin copper per 100 ml of serum (6, 7); 3) a concentration of hepatic copper of more than 150 jug per g of dry liver (12); or 4) the urinary excretion of more than 100 /,g of copper in 24 hours (3, 6, 11, 14, 33) makes it highly probable that he has Wilson's disease which will eventually be manifest clinically.
The sensitivity and specificity of our test in distinguishing the heterozygote, Cc, from the homozygously normal individual, CC, was estimated by comparing the test ratios of Group I (control subjects) with those of Group III (heterozygotes). It was apparent from inspection that the values of R in the control subjects were not normally distributed (Figure 4) . However, log R may be normally distributed, judging from our sample, giving equal variance for tlhe distribution in both heterozygous and control groups. Table I shows that antilog (mean log R)
1.372 and gives the standard deviation for this geometric mean in the 19 control subjects. Table  III gives antilog (mean log R) = 0.510 for the 19 heterozygotes. Statistical analysis (36), applied to the values for log R, indicates that if an individual has an R (not log R) of less than 0.559 he is probably a heterozygote since, with 99 per cent confidence, 10 per cent or less of all homozygously normal individuals have ratios of less than 0.559. If an individual has R greater than 1.253 he is probably homozygously normal since 10 per cent or less of the heterozygote population has ratios greater than 1.253, with 99 per cent certainty. If R falls between 0.559 and 1.253 the individual cannot be classified by this test, since there is too large a risk of error.
The results of the test we have described must obviously be dependent, to some extent at least, on the concentration of ceruloplasmin in the subject's serum. Two questions may, therefore, be asked: 1) how closely are the serum ceruloplasmin concentration and R correlated; and 2) does the ratio discriminate better between heterozygotes and homozygously normal individuals than the ceruloplasmin concentration? To answer these questions correlation coefficients were calculated for ceruloplasmin concentration, and log R, for Groups I and III and found to be 0.42 and -0.04, respectively. Neither of these is significantly different from zero. A plot of the concentration of ceruloplasmin versus log R for the individuals in Group IV, however, suggested a positive correlation, and a correlation coefficient of 0.62, significantly different from zero, was calculated for the combined data of Groups I, III and IV. Consequently, the measurements of ceruloplasmin concentration were analyzed by the same statistical methods used for log R to determine how well these concentrations could differentiate heterozygous from normal individuals. The results were as follows: if a healthy individual has a ceruloplasmin concentration of less than 21.7 mg per 100 ml he is probably a heterozygote (if, of course, he is not homozygously abnormal, cc) since, with 99 per cent certainty, 10 per cent or less of the normal population has a concentration of below 21.7 mg per 100 ml. If a healthy individual has a ceruloplasmin concentration of more than 43.2 mg per 100 ml he is probably homozygously normal, since with 99 per cent certainty, 10 per cent or less of the heterozygote population has a measurement of above 43.2 mg per 100 ml.
Using both the ratio and the ceruloplasmin concentration, we classified 45 asymptomatic members of families in which at least one case of Wilson's disease existed (Table IV) (Tables  II and III) . But such a distinction is generally not difficult to make on other grounds, as already discussed. Occasionally a heterozygous individual like M.D., whose serum concentration of ceruloplasmin is as low as that of a patient with Wilson's disease, will be seen in early life (34, 37) . In such a case measurements of cupriuria, and of the serum concentration of non-ceruloplasmin copper, and analysis of a biopsy specimen of liver for copper may be the only ways to determine whether he is heterozygous or homozygous for the Wilson's disease gene (12) . The distinction is not academic since, in the latter case, he should almost certainly receive treatment (37) .
B. Physiological chemistry. In addition to the four abnormalities in copper metabolism associated with the homozygous state for the Wilson's disease gene, patients with this disease also exhibit an almost complete absence of incorporation of radioactive Cu64 into ceruloplasmin (Table II) (18, (25) (26) (27) (28) 
